...
首页> 外文期刊>Journal of Molecular Endocrinology >Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions
【24h】

Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions

机译:葡萄糖转运蛋白在异位子宫内膜组织和异位子宫内膜异位病变中的表达

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Endometriosis is an extremely prevalent disorder characterized by the growth of endometrial tissue at ectopic locations. Glycolysis is an energy-producing mechanism that occurs in almost all cells and requires an adequate uptake of glucose mediated by glucose transporter (GLUT) proteins. At present, however, very little is known about their expression in either the endometrium or the endometriotic lesions. The objective of this study was to examine the expression of SLC2A genes in the endometrium of women with and without endometriosis and in the matching ectopic tissue, and to confirm the presence of the GLUT proteins in ectopic lesions. There was a significantly higher expression of SLC2A3 and a significantly lower expression of SLC2A4 in women with endometriosis compared with those without. In women with endometriosis, the ectopic expression of SLC2A3, SLC2A4 and SLC2A5 was significantly higher than that observed in the matching eutopic tissue. GLUT1 protein expression was present in both epithelial and stromal cells and GLUT3 was confined to CD45-positive leukocytes. GLUT4 expression was strong in both ectopic epithelial and stromal cells and localized to the cellular membrane in epithelial cells. These results show that GLUT expression is altered between eutopic and ectopic tissue and between women with and without endometriosis, and that GLUT4 may represent a significant entry route for glucose into the endometriotic epithelial cells. The inducible nature of GLUT4 and its limited cellular expression may make GLUT4 an attractive target for non-hormone-based treatments of endometriosis.
机译:子宫内膜异位症是一种非常普遍的疾病,其特征是子宫内膜组织在异位部位生长。糖酵解是一种产生能量的机制,几乎发生在所有细胞中,并且需要由葡萄糖转运蛋白(GLUT)介导的葡萄糖充分摄取。然而,目前对它们在子宫内膜或子宫内膜异位病变中的表达了解甚少。这项研究的目的是检查SLC2A基​​因在子宫内膜异位症和非子宫内膜异位症妇女的子宫内膜以及匹配的异位组织中的表达,并确认异位病变中是否存在GLUT蛋白。与没有子宫内膜异位症的妇女相比,子宫内膜异位症妇女的SLC2A3表达明显较高,而SLC2A4的表达明显较低。在子宫内膜异位症妇女中,SLC2A3,SLC2A4和SLC2A5的异位表达明显高于在匹配的异位组织中观察到的异位表达。 GLUT1蛋白表达同时存在于上皮和基质细胞中,而GLUT3则局限于CD45阳性白细胞。 GLUT4表达在异位上皮和基质细胞中均很强,并位于上皮细胞的细胞膜中。这些结果表明,GLUT表达在异位组织和异位组织之间以及有无子宫内膜异位症的妇女之间发生了变化,并且GLUT4可能代表葡萄糖进入子宫内膜异位上皮细胞的重要途径。 GLUT4的诱导性质及其有限的细胞表达可能使GLUT4成为子宫内膜异位症非基于激素治疗的诱人靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号